lafutidine: Clinical Trials

6 trials of lafutidine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 3 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3
Phase 32Completed 2

Follow lafutidine: new trials by email Literature Review of lafutidine trials Research Report on lafutidine

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Compare the Pharmacokinetics of Lafutidine and Irsogladine Maleate Tablet
BRI-1501, Lafutidine, Irsogladine maleate - Gastric Ulcer
Phase 1CompletedBoryung Pharmaceutical Co., Ltd342016-04-152017-02-07
The Drug-drug Interaction and Safety of Lafutidine and Irsogladine Maleate in Healthy Adult Volunteers
Lafutidine, Irsogladine maleate - Peptic Ulcer
Phase 1CompletedBoryung Pharmaceutical Co., Ltd242015-08-012017-02-06
A Multi-center, Randomized, Double-blind Phase III Clinical Trial to Assess and Compare to the Efficacy and Safety of Lafutidine, Famotidine and Omeprazole-referenced in Korean Erosive Esophagitis Patients
Lafutidine, Famotidine, Omeprazole - Erosive Esophagitis
Phase 3CompletedBoryung Pharmaceutical Co., Ltd4952011-11-012025-01-15
Proton Pump Inhibitors and Risk of Community-acquired Pneumonia
esomeprazole, omeprazole, pantoprazole - Gastroesophageal Reflux Disease (GERD), Community-acquired Pneumonia
CompletedCanadian Network for Observational Drug Effect Studies, CNODES42385042011-09-012015-09-22
Pharmacokinetic Properties and Effect of Food on Pharmacokinetic Properties of the Oral Lafutidine Tablets
lafutidine - Chronic Gastritis
Phase 1CompletedUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology122005-04-012016-01-20
Verification Study on Lafutidine in Mild Reflux Oesophagitis - Double Blind Controlled Study With Famotidine -
Lafutidine, Famotidine, Placebo - Gastroesophageal Reflux
Phase 3CompletedTaiho Pharmaceutical Co., Ltd.3252005-04-012011-07-07

Conditions studied

Gastroesophageal Reflux (2)  ·  Community-Acquired Pneumonia (1)  ·  Esophagitis, Peptic (1)  ·  Peptic Ulcer (1)  ·  Pneumonia (1)  ·  Stomach Ulcer (1)

Sponsors

Boryung Pharmaceutical Co., Ltd (3)  ·  Canadian Network for Observational Drug Effect Studies, CNODES (1)  ·  Taiho Pharmaceutical Co., Ltd. (1)  ·  Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1)

Countries

South Korea (2)  ·  Canada (1)  ·  Japan (1)

Top investigators

Kristian Filion, PhD (1)  ·  Sang Woo Lee (1)  ·  Seoung-hun Han, Professor (1)  ·  Tomoyuki Koike, MD (1)  ·  Weiyong Li, PhD (1)

Results publications

PMID 20379093, PMID 23856153